DrugPatentWatch Database Preview
Sun Pharm Inds Ltd Company Profile
What is the competitive landscape for SUN PHARM INDS LTD, and when can generic versions of SUN PHARM INDS LTD drugs launch?
SUN PHARM INDS LTD has one hundred and two approved drugs.
There is one US patent protecting SUN PHARM INDS LTD drugs. There are two tentative approvals on SUN PHARM INDS LTD drugs.
There are eighteen patent family members on SUN PHARM INDS LTD drugs in eighteen countries and one hundred and forty-two supplementary protection certificates in fourteen countries.
Summary for Sun Pharm Inds Ltd
| International Patents: | 18 |
| US Patents: | 1 |
| Tradenames: | 79 |
| Ingredients: | 77 |
| NDAs: | 102 |
Drugs and US Patents for Sun Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 075439-001 | Apr 19, 2000 | DISCN | No | No | See Pricing | See Pricing | |||||
| Sun Pharm Inds Ltd | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 077542-002 | Aug 6, 2010 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Sun Pharm Inds Ltd | TOPIRAMATE | topiramate | TABLET;ORAL | 076327-002 | Mar 27, 2009 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Sun Pharm Inds Ltd | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 065132-001 | Mar 19, 2003 | DISCN | No | No | See Pricing | See Pricing | |||||
| Sun Pharm Inds Ltd | LEVOCETIRIZINE DIHYDROCHLORIDE | levocetirizine dihydrochloride | TABLET;ORAL | 201653-001 | Jun 26, 2015 | AB | RX | No | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Sun Pharm Inds Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2416767 | See Pricing |
| Poland | 365135 | See Pricing |
| Slovakia | 2102003 | See Pricing |
| Israel | 154307 | See Pricing |
| Russian Federation | 2003104808 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1261586 | 15/2012 | Austria | See Pricing | PRODUCT NAME: KOMBINATIONSPRODUKT VON SAXAGLIPTIN UND METFORMIN UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON, BEINHALTEND DIE HYDROCHLORIDSALZE VON SAXAGLIPTIN UND METFORMIN; REGISTRATION NO/DATE: EU/1/11/731/001-EU/1/11/731/012 20111124 |
| 0503785 | CA 2011 00026 | Denmark | See Pricing | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
| 1003503 | C01003503/01 | Switzerland | See Pricing | PRODUCT NAME: AMLODIPIN + ATORVASTATIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 57633 05.07.2006 |
| 0984957 | CR 2012 00035 | Denmark | See Pricing | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
| 0138441 | SPC/GB95/028 | United Kingdom | See Pricing | PRODUCT NAME: TOPIRAMATE; REGISTERED: UK 0242/0301 19950718 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
